SB

Santosh Bhakare Laxman

Director Director DIN 06902661
DIN 06902661 First appointment Sep 2014 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Sep 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Santosh Bhakare Laxman

Data last updated:

Santosh Bhakare Laxman has 12 years in corporate governance. Formerly with 1 company, such as Yomaris Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06902661
Primary Designation Director
First Appointment 10 Sep 2014
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yomaris Pharma Private Limited U51101MH2014PTC257952
Director10 Sep 20142014₹11.8 Lakh (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Yomaris Pharma Private Limited
Premium access

Shareholding and investment profile for Santosh Bhakare Laxman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Bhakare Laxman

Santosh Bhakare Laxman has 12 years in corporate governance. Formerly with 1 company, such as Yomaris Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Santosh Bhakare Laxman has expertise in General Business.

Santosh Bhakare Laxman has 12 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available